NCT04939194 Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. Status UNKNOWN Phase PHASE3
NCT04923178 A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies Status RECRUITING Phase N/A
NCT04917809 A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04900259 The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations Status COMPLETED Phase N/A
NCT04897763 Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC Status COMPLETED Phase EARLY_PHASE1
NCT04887831 Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab Status TERMINATED Phase PHASE2
NCT04878250 Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder Status UNKNOWN Phase PHASE2
NCT04838873 Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center Status COMPLETED Phase NA
NCT04825834 DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) Status COMPLETED Phase N/A
NCT04806178 Immunological Response of Bladder Cancer Patients Under BCG Status COMPLETED Phase PHASE3
NCT04799847 Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine Status UNKNOWN Phase PHASE1/PHASE2
NCT04779489 Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer Status TERMINATED Phase NA
NCT04770974 Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic Status UNKNOWN Phase N/A
NCT04768894 Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates Status COMPLETED Phase NA